Gamma-Oryzanol

Spezifikationen

11042-64-1CAS-Nummer

244-285-1EG-Nummer

[(1S,3R,6S,8R,11S,12S,15R,16R)-7,7,12,16-tetramethyl-15-[(2R)-6-methylhept-5-en-2-yl]-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoateIUPAC-Name

C40H58O4Chemische Formel

602.9 g/molMolekulargewicht

gamma-Oryzanol; gamma Oryzanol; 11042-64-1; Gammariza; Oliver; SST9XCL51M; DTXSID6021084; RefChem:856958; 600-960-6; Cycloartenyl ferulate; gamma-Orizanol; HI-Z; 21238-33-5; Gamma oryzanol [JAN]; UNII-SST9XCL51M; Cycloartenol Trans-Ferulate; Cycloartenol ferulate; Oryzanol A; 3-O-Ferulylcycloartenol; 3PQR2YON9T; Ferulic acid cycloartenol ester; gamma Oryzanol (JAN); DSSTox_CID_1084; DSSTox_RID_75932; DSSTox_GSID_21084; Cycloartenol ferulic acid ester; C40H58O4; [(1S,3R,6S,8R,11S,12S,15R,16R)-7,7,12,16-tetramethyl-15-[(2R)-6-methylhept-5-en-2-yl]-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; CAS-11042-64-1; GammaOryzanol; Oryzanol A (Cycloartenyl Ferulate); CCRIS 4251; NCGC00181756-01; (2aR,3R,5aS,5bS,7aR,9S,11aR,12aS)-2a,5a,8,8-tetramethyl-3-((R)-6-methylhept-5-en-2-yl)tetradecahydro-1H,12H-cyclopenta[a]cyclopropa[e]phenanthren-9-yl 3-(4-hydroxy-3-methoxyphenyl)acrylate; 9,19-CYCLOLANOST-24-EN-3-OL, 3-((2E)-3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOATE), (3.BETA.)-; 9,19-Cyclolanost-24-en-3-ol, 3-[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate], (3.beta.)-; gamma-Oryzanol (TN); ORYZANOL A [MI]; UNII-3PQR2YON9T; Hi-Z (TN); Cycloartenol, trans-ferulate; OZ; SCHEMBL718726; (3beta)-9,19-Cyclolanost-24-en-3-yl 4-hydroxy-3-methoxycinnamate; CHEMBL388595; orb1304006; SCHEMBL29354302; CHEBI:32345; MSK11173; EINECS 244-285-1; Tox21_112482; BDBM50483936; LMST05050066; AKOS016339566; AKOS040757309; Tox21_112482_1; CCG-270201; FO26593; gamma-Oryzanol; 3-O-Ferulylcycloartenol; DA-52220; HY-125938; CS-0103198; T3606; 9beta,19-cyclolanost-24-en-3beta-yl ferulate; D01221; E88692; T39570; O710990; Q27257875; 9,19-Cyclo-9beta-lanost-24-en-3beta-ol 4-hydroxy-3-methoxycinamate; 9,19-CYCLO-9.BETA.-LANOST-24-EN-3.BETA.-OL 4-HYDROXY-3-METHOXYCINAMATE; 9,19-CYCLO-9.BETA.-LANOST-24-EN-3.BETA.-OL, 4-HYDROXY-3-METHOXYCINNAMATE; (2aR,3R,5aS,5bS,7aR,9S,11aR,12aS)-2a,5a,8,8-tetramethyl-3-((R)-6-methylhept-5-en-2-yl)tetradecahydro-1H,12H-cyclopenta[a]cyclopropa[e]phenanthren-9-yl (E)-3-(4-hydroxy-3-methoxyphenyl)acrylate; [(1S,3R,6S,8R,11S,12S,15R,16R)-15-[(1R)-1,5-dimethylhex-4-enyl]-7,7,12,16-tetramethyl-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoate; 286011-27-6; 9,19-CYCLOLANOST-24-EN-3-OL, (2E)-3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOATE, (3.BETA.)-; 9,19-CYCLOLANOST-24-EN-3-OL, 3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOATE, (3.BETA.)-; CINNAMIC ACID, 4-HYDROXY-3-METHOXY-, 9,19-CYCLO-9.BETA.-LANOST-24-EN-3.BETA.-YL ESTER; Y-OryzanolSynonyme